| Dr Joshua Lane Woelk, MD | |
|
1021 Bandana Blvd E Ste 100, Saint Paul, MN 55108-5109 | |
| (651) 241-9700 | |
| (651) 241-9678 |
| Full Name | Dr Joshua Lane Woelk |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 1021 Bandana Blvd E Ste 100, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043403363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 52408 (Minnesota) | Secondary |
| 207VF0040X | Obstetrics & Gynecology - Female Pelvic Medicine And Reconstructive Surgery | 52408 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allina United Hospital | Saint paul, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
Researchers at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech have released findings that explain how a type of healthy bacteria in yogurt and other dairy products might reduce disease symptoms in certain patients with lupus.
Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.
Life Science Pharmaceuticals (LSP) announced today a milestone related to monoclonal-antibody (mAb) 806 licensed to Abbott. A Phase 1 trial with ABT-806, a humanized version of mAb 806 that selectively targets the epidermal growth factor receptor (EGFR), has been initiated by Abbott in the U.S. The trial will assess the safety and pharmacokinetics of ABT-806 in patients with advanced solid tumors likely or known to express EGFR.
› Verified 3 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
Researchers at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech have released findings that explain how a type of healthy bacteria in yogurt and other dairy products might reduce disease symptoms in certain patients with lupus.
Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.
Life Science Pharmaceuticals (LSP) announced today a milestone related to monoclonal-antibody (mAb) 806 licensed to Abbott. A Phase 1 trial with ABT-806, a humanized version of mAb 806 that selectively targets the epidermal growth factor receptor (EGFR), has been initiated by Abbott in the U.S. The trial will assess the safety and pharmacokinetics of ABT-806 in patients with advanced solid tumors likely or known to express EGFR.
› Verified 3 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
Researchers at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech have released findings that explain how a type of healthy bacteria in yogurt and other dairy products might reduce disease symptoms in certain patients with lupus.
Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.
Life Science Pharmaceuticals (LSP) announced today a milestone related to monoclonal-antibody (mAb) 806 licensed to Abbott. A Phase 1 trial with ABT-806, a humanized version of mAb 806 that selectively targets the epidermal growth factor receptor (EGFR), has been initiated by Abbott in the U.S. The trial will assess the safety and pharmacokinetics of ABT-806 in patients with advanced solid tumors likely or known to express EGFR.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Lane Woelk, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-9000 | Dr Joshua Lane Woelk, MD 1021 Bandana Blvd E Ste 100, Saint Paul, MN 55108-5109 Ph: (651) 241-9700 |
News Archive
Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
Researchers at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech have released findings that explain how a type of healthy bacteria in yogurt and other dairy products might reduce disease symptoms in certain patients with lupus.
Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.
Life Science Pharmaceuticals (LSP) announced today a milestone related to monoclonal-antibody (mAb) 806 licensed to Abbott. A Phase 1 trial with ABT-806, a humanized version of mAb 806 that selectively targets the epidermal growth factor receptor (EGFR), has been initiated by Abbott in the U.S. The trial will assess the safety and pharmacokinetics of ABT-806 in patients with advanced solid tumors likely or known to express EGFR.
› Verified 3 days ago
Susan J Ditmanson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 347 Smith Ave N, Suite 203, Saint Paul, MN 55102 Phone: 651-241-7733 | |
Christina Hyein Swallow, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 435 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-8500 Fax: 651-254-8504 | |
Sureshbabu N Ahanya, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 347 Smith Ave N, 204, Saint Paul, MN 55102 Phone: 651-241-6270 Fax: 651-220-5185 | |
Dr. Shariska Petersen Harrington, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 310 Smith Ave N Ste 100, Saint Paul, MN 55102 Phone: 651-251-5500 | |
Dr. David Jize Wen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 347 Smith Ave N, Suite 203, Saint Paul, MN 55102 Phone: 651-241-7733 Fax: 651-241-7798 | |
Joan E Kreider, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2635 University Ave Suite 160, Mail Stop 13901b, Saint Paul, MN 55114 Phone: 651-254-3500 Fax: 651-254-3699 | |
Dr. Stephanie Michelle Allen, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2635 University Ave W Ste 160, Saint Paul, MN 55114 Phone: 651-254-3500 |